• Discuss the epidemiology and pathophysiology of PE, including how to assess the risk of patients presenting with symptoms consistent with PE.
• Identify features that define low, intermediate and high‐risk PE
• Develop a diagnostic and treatment algorithm that incorporates risk stratification and meets the specific needs of patients presenting with signs and symptoms of PE.
• Appropriately select among various treatment options for intermediate‐ and high‐risk PE patients including: anticoagulation, fibrinolysis (intravenous and catheter‐directed), extra‐corporeal membrane oxygenation (ECMO), thrombectomy (suction and surgical), and IVC filter placement.
• Recognize the potential acute complications of PE and how to prevent and treat them.
• Develop algorithm to identify and manage long term consequences of PE, such as CTEPH and CTED; understand combination of pharmacologic and mechanical treatment options available for use in such patients.
• Describe unique patient populations with PE and their specific treatment challenges
• Discuss the benefits of a multidisciplinary approach to PE management, and how to implement a PE Response Team (PERT) in their hospital.
• Identify what constitutes high quality care for PE.
• Target opportunities for quality improvement at an institutional level.
• Address thrombosis issues related to COVID-19, specifically:
• Delineate the risk of thrombosis associated with COVID-19 infection
• Characterize the various manifestations and presentations of thrombosis and VTE seen with COVID-19, including the VITT syndrome
• Identify the proper testing pathways for COVID-19 associated clotting disorders
• Specify anticoagulation regimens currently utilized to treat active thrombosis, as well as the range of therapeutics available as prophylaxis to prevent recurrence in hospitalized patients.
• Delineate proper anticoagulation strategies for hospitalized COVID-19 patients
• Define proper anticoagulation for outpatients with active or convalescent infection
• Prescribe appropriate treatment/prophylaxis after discharge of COVID-19 patients
• Define the value and benefits of the multi-disciplinary approach in the management of PE and VTE, including the PERT approach
• Establish the role of PERT in COVID-19 patient, including adjustments in the treatment paradigms necessitated by active infection

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and PERT Consortium. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 15 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.